PTS Pulse

0
by in

PTS, Inc. Acquires A1CNow and Expands Product Portfolio

PTS, Inc. Acquires A1CNow and Expands Product Portfolio

Indianapolis, IN – December 20, 2013- Polymer Technology Systems, Inc. (PTS, Inc.), the U.S. based manufacturer of the CardioChek family of Point-of-Care diagnostic products, announced today that it has acquired the A1CNow family of products from Bayer Diabetes Care. The A1CNow+® Multi-test A1C System and A1CNow® SELFCHECK At-Home A1C System are important testing devices for readily monitoring A1C levels. The tests provide healthcare providers and people with diabetes with an indicator of the patient’s average blood glucose control over approximately the past 3 months.

“We’re very excited about the addition of the A1CNow system to the PTS product portfolio,” says Robert Huffstodt, President and CEO of PTS, Inc. “There is an established relationship between A1c levels, lipid levels and the risk for complications of diabetes, and the A1CNow products are important tools in helping providers and patients understand how well their diabetes treatment plan is working.”

The A1CNow acquisition strengthens the PTS product portfolio by adding testing capabilities that are being requested by many current PTS customers. The A1CNow system’s rapid results and mobility features enable healthcare providers to communicate face-to-face with patients about their diabetes control thus, providing optimum Point-of-Care convenience.

“We believe this acquisition is good news for PTS customers and A1CNow customers alike,” explains Huffstodt. “We’re eager to begin providing A1CNow systems to our global markets as soon as possible to help deliver vital information for healthcare providers and people with diabetes around the world.” Manufacturing will continue at the current plant in Sunnyvale, CA and product availability details will be forthcoming.

About Polymer Technology Systems, Inc. (PTS, Inc.) – Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America and the Pacific Rim. PTS, Inc. products include the CardioChek PA Point-of-Care instrument which is marketed to the professional diagnostics industry, the CardioChek cholesterol analyzer for consumer use, and now the new CardioChek Plus analyzer. The company offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com. For further information, please contact:

Laura Wilkerson
Director of Marketing
Polymer Technology Systems, Inc.
7736 Zionsville Road
Indianapolis, IN 46268
317-870-5610

All trademarks used or mentioned in this release are protected by law.

SOURCE Polymer Technology Systems, Inc.
LIT 001610 Rev. 0 12/13
0
by in

PTS Diagnostics Now Shipping A1CNow®+ Systems

PTS Diagnostics Now Shipping A1CNow®+ Systems

Indianapolis, IN – May 6, 2014- PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow family of point-of-care diagnostic products, announced today that they have started shipping A1CNow+ systems to their distributor network. Just four months ago, PTS Diagnostics acquired the A1CNow family of products from Bayer Diabetes Care.

“A1CNow systems are important to healthcare providers and patients worldwide,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “So, it was critical for us to facilitate a seamless transition and deliver the products in a timely manner.”

Ben Irvin, Director of A1CNow Research and Development, was a member of the team that developed the original A1CNow system in the early 2000s. “All of us in Sunnyvale, CA, are excited to be part of PTS Diagnostics. Their expertise in diagnostic device manufacturing, scientific knowhow, and established distribution network make this affiliation a perfect fit for the A1CNow family of products. We are also pleased that we were able to retain over 50 of our key people and that manufacturing and development will continue at the current plant in Sunnyvale.”

Not only did PTS Diagnostics acquire a high-quality and well-known product family, the company also purchased a proven manufacturing facility and is pleased to also employ so many associates that have a deep institutional knowledge of the A1CNow technology.

“We are delighted to welcome these former Bayer A1CNow employees and their customers to the PTS Diagnostics family. This has been an extraordinarily fast and easy transition. We are proud to be shipping product this quickly,” Huffstodt continued. “We know there is significant pent-up demand for the A1CNow+, and are pleased to be able to provide product without further delay.”

A1CNow+ empowers healthcare professionals to provide individuals with an indicator of average blood glucose control for the past 2 to 3 months.

About PTS Diagnostics – PTS Diagnostics is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS Diagnostics’ products include the CardioChek systems and A1CNow point-of-care systems. The company also offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.ptsdiagnostics.com or contact Laura Wilkerson at 317-870-5610.

All trademarks used or mentioned in this release are protected by law.

MKG001345 Rev. 0 03/15
0
by in

PTS Diagnostics Introduces A1CNow® SELFCHECK Analyzer

PTS Diagnostics Introduces A1CNow® SELFCHECK Analyzer

Medical device provides at-home A1c monitoring in less than 5 minutes

Indianapolis, IN– Sept. 3, 2014 – Consumers now have the ability to test their A1c from home in less than 5 minutes thanks to PTS Diagnostics’ introduction of the A1CNow SELFCHECK system.

A1CNow SELFCHECK is a consumer-friendly medical device that provides a fast, easy and accurate at-home testing method for obtaining HbA1c results. In just five minutes, people can get an idea of their 2- to 3-month average blood glucose control.

A1CNow SELFCHECK is now available for purchase online at www.a1cnowselfcheck.com.

“The A1CNow SELFCHECK system is an important tool for diabetes management,” said James Anderson, MD, PTS Diagnostics’ medical director. “People with diabetes who desire an at-home monitoring system to measure their A1c between physician office visits now have a simple way to aid their self-management. Consumers can know that the A1CNow SELFCHECK system provides accuracy comparable to a certified laboratory method.1.”

Robert Huffstodt, President and CEO of PTS Diagnostics, commented that the consumer product is essentially the same as the A1CNow+ system used by medical professionals. “A1CNow systems are trusted by medical professionals across the country,” Huffstodt said. “The A1CNow SELFCHECK system uses a very small blood sample from a simple fingerstick. The system is affordable, fast, easy-to-use, and requires no maintenance.”

The A1CNow SELFCHECK system comes in a convenient 2-test pack with the items the consumer needs to complete both tests (monitor, test cartridges, fingerstick lancets and blood collectors.)

“A scientific study has demonstrated that just a 1 percentage point reduction in a patient’s A1c level may reduce their risk of complications by up to 40 percent2,” said Dr. Anderson. “Many doctors would agree that when a person with diabetes regularly monitors their A1c levels, they tend to pay closer attention to their diet and, often times, lower the average glucose level in the blood. By regularly monitoring their A1c, a patient can better manage their diabetes.”

About PTS Diagnostics – PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products. The company is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim.

For more information, visit http://www.a1cnowselfcheck.com or contact Tom Wiser at 317-870-5610.

All trademarks used or mentioned in this release are protected by law.

1. NGSP Certificate September 1, 2014: ptsdiagnostics.com
2. Stratton IM, Adler Al, Neil AW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ. 2000;321:405-412.
MKG001105 Rev.1 03/15
0
by in

PTS Diagnostics Named to Inc. Magazine’s 5000 Fastest Growing Private Companies List for the Fourth Time

PTS Diagnostics Named to Inc. Magazine’s 5000 Fastest Growing Private Companies List for the Fourth Time

Indianapolis, IN – September 15, 2014 — PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, has again been named to the Inc. 5000 list of the fastest-growing private companies in America. The Inc.5000 ranking is based on revenue growth over a three-year period. PTS Diagnostics earned its place on the list by growing its revenue by 80 percent from 2010 to 2013.

For PTS Diagnostics, who appears on the list as Polymer Technology Systems, this is the second consecutive year on the list and the fourth time in its history. PTS Diagnostics is the only Indiana medical device manufacturer that made the list in 2014 and has made the list four or more times.

“We are especially pleased with this distinction this year,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “Our continued growth is a result of our commitment to manufacture and distribute a broad portfolio of diagnostic solutions for point-of-care healthcare providers. It’s gratifying for all of us to see our growth strategies validated in the marketplace and recognized by the media.”

PTS Diagnostics is experiencing rapid growth with its solutions that aid healthcare professionals in measuring HbA1c and glucose, and generating lipid (cholesterol) profiles, all at the point of care. “The essence of our mission is to improve health,” continued Huffstodt. “We can now provide fast, easy-to-use, accurate, point-of-care diagnostics for multiple key disease states, including high cholesterol and diabetes. Furthermore, we focus on the relationship with our distributors and customers encompassing our proven technology and point-of-care solutions.”

“We continue to build on this momentum,” concluded Huffstodt. “We have recently added new distribution partners to further expand our market reach; made key hires for our research, technology, sales, and marketing teams; and we have invested significantly in our manufacturing and quality control areas. We are excited to continue our ongoing commitment to providing a full suite of world-class point-of-care diagnostic solutions to healthcare professionals of all kinds, all around the world.”

PTS Diagnostics’ portfolio includes the following systems:
  • The CardioChek Plus analyzer addresses the connection between heart attack, stroke, and diabetes by providing simultaneous on-site lipid panel (total cholesterol, HDL cholesterol, and triglycerides) and glucose screening results in as little as 90 seconds. The CardioChek Plus also calculates LDL cholesterol, the TC/HDL ratio, the LDL/HDL ratio, and non-HDL cholesterol.
  • The A1CNow+ system provides healthcare professionals with a fast, easy, and accurate method of obtaining HbA1c results while the patient is in the exam room. In just five minutes, clinicians have information to provide an immediate consultation with a patient. The A1CNow+ system is critical to diabetes management and is fully reimbursable.

    • About PTS Diagnostics – PTS Diagnostics is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS Diagnostics’ products include both the CardioChek systems and A1CNow systems.

    About Inc. 5000 – The Inc. 500|5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success. The Inc. 5000 profiles are available on Inc.com.

    All trademarks used or mentioned in this release are protected by law.

    For more information, visit www.ptsdiagnostics.com or contact Tom Wiser at 317-870-5610.

    MKG001115 Rev.1 03/15
    0
    by in

    PTS Diagnostics Unveils New Capillary Tube

    PTS Diagnostics Unveils New Capillary Tube

    Advanced blood collection technology combines speed, efficiency and savings

    Indianapolis – January 21, 2015 – PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, today announced that it has launched a line of capillary tubes using a new and innovative technology. The PTS Diagnostics Capillary Tubes, which provide speed, efficiency and savings — especially for applications where exact sample volumes are required — are now available from PTS Diagnostics’ distributors around the world.

    PTS Diagnostics Capillary Tubes provide better efficiency and are designed to be easier to use than traditional blood transfer tubes. Using a single glass tube with plastic casing, the PTS Diagnostics Capillary Tubes provide consistent selfwicking technology to deliver preset volumes. This improved design is perfect for blood collection needs addressing a wide range of applications across many different medical devices. In addition, the new PTS Diagnostics Capillary Tubes provide significant savings over traditional pipettes with the same or better quality.

    These new PTS Diagnostics Capillary Tubes can increase efficiency in workflow by providing: 

  • Ease-of-use with no assembly
  • One-hand blood collection and dosing
  • A glass tube to ensure easy blood collection
  • Bulb-squeeze dispensing technology that ensures consistent performance
  • Only one item to inventory (no plunger)

    • “In the health screening, workplace health and physician office environments, this new design provides many advantages over traditional blood transfer tubes,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “PTS Diagnostics Capillary Tubes are ideal for low volume blood collection given the product’s one-hand operation, no assembly and precise self-wicking collection to preset volumes. This new technology combines speed, efficiency and savings.”

    These new capillary tubes are designed to be easy-to-use and require little additional training.

    “PTS Diagnostics is known for its lipid testing and A1C monitoring devices, however this new product will help us expand our reach across point-of-care testing as the new capillary tubes provide savings and efficiency across many tests including ABO/Rh Blood, IgE, HIV, hepatitis and various other infectious diseases to name a few,” said Huffstodt.

    PTS Diagnostics’ handheld, highly-accurate, fast, and economical diagnostic devices empower the medical community to quickly measure HbA1c and glucose, and generate a lipid (cholesterol) profile, all at the point of care.

    PTS Diagnostics’ portfolio includes the following systems:

  • CardioChek professional analyzers address the connection between heart attack, stroke, and diabetes by providing on-site lipid panel (total cholesterol, HDL cholesterol, and triglycerides) screening results in as little as 90 seconds and can also measure glucose. CardioChek professional analyzers calculate LDL cholesterol, the TC/HDL ratio, the LDL/HDL ratio, and non-HDL cholesterol.
  • The A1CNow+ system provides healthcare professionals with a fast, easy, and accurate method of obtaining HbA1c results while the patient is in the exam room. In just five minutes, clinicians have information to provide an immediate consultation with a patient. The A1CNow+ system is critical to diabetes management and is fully reimbursable.

    • About PTS Diagnostics – PTS Diagnostics is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS Diagnostics’ products include both the CardioChek systems and A1CNow systems.

    All trademarks used or mentioned in this release are protected by law.

    For more information, visit www.ptsdiagnostics.com or contact Tom Wiser at +1-317-870-5610.

    MKG001159 Rev. 0 1/15